MAIA Biotechnology, Inc. (MAIA): auditor change — MAIA Biotechnology dismisses EisnerAmper, appoints Grant Thornton as auditor

MAIA Biotechnology, Inc.

Dismissed EisnerAmper as independent auditor on Nov 21, 2022; no disagreements or reportable events.
Engaged Grant Thornton for fiscal year ending Dec 31, 2022, effective immediately.
EisnerAmper's reports for 2020 and 2021 were unqualified with no adverse opinions.
Company confirms no prior consultations with Grant Thornton on accounting issues.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

MAIA Biotechnology, Inc. engaged Grant Thornton LLP as its auditor.

Action: engagement
Auditor: Grant Thornton LLP

Exact text from the filing

On November 21, 2022, upon the approval of the Audit Committee, the Company engaged Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022, effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

MAIA Biotechnology, Inc. dismissed EisnerAmper LLP as its auditor.

Action: dismissal
Auditor: EisnerAmper LLP
Successor: Grant Thornton LLP

Exact text from the filing

On November 21, 2022, upon the approval of its Audit Committee of the Board of Directors (the “Audit Committee”) of MAIA Biotechnology , Inc. (the "Company"), the Company dismissed EisnerAmper LLP ("EisnerAmper") as the Company’s independent registered public accounting firm.

View on SEC.gov

6 auditor changes filed in the last 30 days. Browse all auditor changes →

MAIA Biotechnology, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-22-038110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.